- Serum Sclerostin in Hepatitis C Virus Infected Patients
-
Gonzalez-Reimers E, Lopez-Prieto J, Pelazas-Gonzalez R, Aleman-Valls MR, Jose de la Vega-Prieto M, Jorge-Ripper C, Duran-Castellon MC, Santolaria-Fernandez F
- KMID: 2391955
- J Bone Metab.
- 2014 Feb;21(1):69-75.
BACKGROUND: Sclerostin inhibits osteoblast functions, differentiations, and survival rates. As an endogenous inhibitor of the Wnt/beta-catenin pathway, the sclerostin should be related to decreased bone masses, although several studies indicate... -
- CITED
-
- Close
- SHARE
-
- Close
